i-Base home
Search Menu
  • Home
  • HTB
  • HIV 12 Glasgow 2014

HTB

HIV 12 Glasgow 2014

12th Glasgow Congress on HIV Therapy, 2-6 November 2014, Glasgow

1 December 2014. Related: Conference reports.

Savings to the NHS predicted from switching to generic antiretrovirals

1 December 2014. Related: Conference reports, Antiretrovirals, Treatment access.

Lower dose efavirenz effective in two studies

1 December 2014. Related: Conference reports, Antiretrovirals.

Should tenofovir dose be 200 – 250 mg when used with protease inhibitors?

1 December 2014. Related: Conference reports, Antiretrovirals.

3TC inferior to FTC in Dutch cohort but interchangeable in other studies

1 December 2014. Related: Conference reports, Antiretrovirals.

Suicide not associated with efavirenz use in the D:A:D cohort study

1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.

Gender differences in use of cardiovascular disease-related interventions: D:A:D study

1 December 2014. Related: Conference reports, Treatment strategies, Women's health, Side effects.

Efavirenz decreases exposure to hormonal contraceptive implant

1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.

Increased risk of ART-related hepatotoxicity in HIV positive pregnant women

1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy, Side effects.

Darunavir pharmacokinetics in pregnancy and postpartum

1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy.

  • HTB RSS

Early access

  • Zero transmission in France for mothers on ART from conception with undetectable viral load at delivery 30 January 2023
  • 56 Dean Street as a nurse-led PrEP clinic: >20,000 clients in 2021 27 January 2023
  • Phase 3 Mosaico HIV vaccine efficacy trial stopped early due to lack of benefit 27 January 2023
  • All early access reports

Current issues

  • January 2023
  • December 2022
  • October 2022
  • Back issues

Special report

  • Latest statistics on HIV in the UK: data for 2021 1 December 2022

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook
i-Base on Facebook